Ayala Pharmaceuticals Depreciation & Amortization 2011-2026 | AYLA

Annual Depreciation & Amortization Ayala Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
162 K	168 K	182 K	150 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
182 K	150 K	166 K

Quarterly Depreciation & Amortization Ayala Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	121 K	81 K	30 K	-	140 K	94 K	164 K	-	138 K	89 K	53 K	-	47 K	28 K	20 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
164 K	20 K	83.8 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alector ALEC	5.72 M	$ 2.13	-12.55 %	$ 219 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
BioCardia BCDA	84 K	$ 1.37	6.2 %	$ 29 M	USA
Black Diamond Therapeutics BDTX	343 K	$ 2.4	-2.83 %	$ 132 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
BioXcel Therapeutics BTAI	309 K	$ 1.64	-1.8 %	$ 4.16 M	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
BeyondSpring BYSI	61 K	$ 1.44	6.3 %	$ 58.1 M	USA
Cabaletta Bio CABA	1.43 M	$ 3.34	0.6 %	$ 3.9 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.7	2.49 %	$ 1.11 B	Canada
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Codexis CDXS	4.95 M	$ 1.05	3.47 %	$ 77.1 M	USA
Cerus Corporation CERS	1.86 M	$ 2.6	1.56 %	$ 480 M	USA
Certara CERT	75.2 M	$ 7.17	1.27 %	$ 1.15 B	USA
Cullinan Management CGEM	306 K	$ 15.91	2.65 %	$ 931 M	USA
Compugen Ltd. CGEN	461 K	$ 2.28	25.97 %	$ 204 M	Israel
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Coherus BioSciences CHRS	3.2 M	$ 1.66	-0.9 %	$ 156 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
CNS Pharmaceuticals CNSP	3.31 K	$ 3.1	-0.44 %	$ 1.18 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Cocrystal Pharma COCP	126 K	$ 1.02	-0.97 %	$ 10.4 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Collegium Pharmaceutical COLL	4.18 M	$ 42.0	0.79 %	$ 1.33 B	USA
Corcept Therapeutics Incorporated CORT	1.15 M	$ 35.61	-0.25 %	$ 3.7 B	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA